ERBA Diagnostics (ERB Posts Surprise Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
ERBA Diagnostics, Inc. Reports 1st Quarter 2015 Financial Results
June 26, 2015 6:05 PM EDTMIAMI LAKES, Fla., June 26, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, today announced first quarter 2015 financial results. During the first quarter of 2015, ERBA Diagnostics recorded revenue of $4.9 million and net loss of $1.0 million. This compares to revenue of $6.4 million and net income of $0.2 million for the first quarter of 2014. Gross margin decreased to 43% with gross profit of $2.1 million in the first quarter of 2015, compared to gross margin of 46% with gross profit of $2.9 million for the same period in 2014.
Revenues in the first quarter... More
ERBA Diagnostics, Inc. Reports 1st Quarter 2015 Financial Results
June 26, 2015 6:05 PM EDTMIAMI LAKES, Fla., June 26, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, today announced first quarter 2015 financial results. During the first quarter of 2015, ERBA Diagnostics recorded revenue of $4.9 million and net loss of $1.0 million. This compares to revenue of $6.4 million and net income of $0.2 million for the first quarter of 2014. Gross margin decreased to 43% with gross profit of $2.1 million in the first quarter of 2015, compared to gross margin of 46% with gross profit of $2.9 million for the same period in 2014.
Revenues in the first quarter... More
